Peptide
Reference library
Educational peptide reference — research use only.
Research & educational use only
For laboratory and educational research only. Not for human or veterinary consumption. This is not medical advice. Always follow applicable laws and consult qualified professionals.
The calculator performs unit math for research reference. It must not be used to plan or guide dosing in humans or animals. Verify all figures independently in your lab protocol.
PEG MGF
A pegylated IGF-1 splice variant studied in muscle-repair research.
- Half-life (approx.)
- ~hours (approx., pegylation extended)
- Diluent
- Bacteriostatic water (0.9% benzyl alcohol)
- Common vials
- 2 mg
Half-life figures are literature approximations for educational reference — not pharmacokinetic advice.
Overview
PEG-MGF is a pegylated splice variant of IGF-1 (mechano growth factor) studied for localized muscle-repair signaling after mechanical load. Pegylation extends half-life compared to native MGF in tissue-repair research models. Pegylated mechano growth factor for local muscle repair at mechanical injury sites.
Structure & identity
PEGylated IGF-1 Ec (mechano growth factor splice variant)
- Sequence / structure
- PEGylated IGF-1 Ec (mechano growth factor splice variant)
Mechanism
Pegylated mechano growth factor splice variant activates local IGF-1R in damaged muscle. IGF-1 Ec splice variant targets damaged muscle fiber niches in load-injury models.
Studies & clinical programs
Mechanical load muscle injury
Published research models
- Peer-reviewed literature documents endpoints under Mechanical load muscle injury experimental designs.
Satellite cell activation
Published research models
- Peer-reviewed literature documents endpoints under Satellite cell activation experimental designs.
Research models in literature
- Mechanical load muscle injury
- Satellite cell activation
Literature highlights
- Pegylated mechano growth factor splice variant activates local IGF-1R at injury sites.
- Satellite cell activation studied after mechanical muscle load and crush injury.
- Pegylation extends half-life versus unmodified MGF in muscle-repair models.
Combination research notes
Muscle repair research pairs PEG-MGF with TB-500 and IGF-1 LR3 in published literature.
Key targets & pathways
Research areas
Routes in research literature
Also known as
Stability & storage phases
| Phase | Condition | Guidance |
|---|---|---|
| Lyophilized | Sealed vial, refrigerated (2–8 °C) | Intact lyophilized cake or powder is typically stable for months to years per published stability data; protect from moisture, light, and repeated freeze-thaw of the dry vial. |
| Reconstituted | Bacteriostatic water (0.9% benzyl alcohol), refrigerated | Most aqueous peptide solutions remain usable for approximately 2–4 weeks refrigerated; verify published stability data and label with reconstitution date. |
| Working aliquots | Pre-drawn syringes or microtubes, frozen (−20 °C) | Aliquot promptly after mixing to limit freeze-thaw cycles on the main vial; thaw once and use to reduce protease-mediated degradation. |
Stability windows are formulation-dependent — verify published data and your lab SOP.
Reconstitution reference table
| Vial (mg) | Diluent (mL) | mcg/mL | Units @ 100 mcg | Units @ 250 mcg | Units @ 500 mcg |
|---|---|---|---|---|---|
| 2 | 2 | 1000.0 | 10 | 25 | 50 |
U-100 insulin syringe scale (100 units = 1 mL). Illustrative only — not dosing guidance.
Reconstitution steps
- Allow vial to reach room temperature (15–30 min)
- Swab rubber stopper with alcohol prep pad
- Draw calculated bacteriostatic water into syringe
- Inject diluent slowly down vial wall — do not spray directly onto cake
- Gently swirl until fully dissolved — do not shake vigorously
- Label with date, concentration, and diluent volume
- Refrigerate and use within your lab stability window
Typically reconstituted with 1–2 mL bacteriostatic water.
Laboratory record checklist
- Compound identity recorded in lab notebook (name, lot, preparation date)
- Analytical identity cross-checked against published sequence or structure
- Potency or concentration documented from analytical certificate when available
- Purity or HPLC data filed when provided with research material
- Appearance noted: intact lyophilized cake or uniform powder
- Sterility / endotoxin report archived when available
- Storage temperature applied immediately per published stability guidance